SCHEMBL28864679

SCHEMBL28864679

CC(C)(C)OC(=O)CN1CCCOCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.47
USP2 O75604 1/20 0.47
KDM4E B2RXH2 4/20 0.46
HSD17B10 Q99714 2/20 0.44
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
RECQL P46063 1/20 0.39
HTR4 Q13639 1/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 1/20 0.39
GLA P06280 1/20 0.39
EGFR P00533 1/20 0.37
HTT P42858 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
CTSD P07339 1/20 0.36
CTSL P07711 1/20 0.36
CTSB P07858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12014405 0.93 SMN1; SMN2 (0.53) SMN1; SMN2USP2KDM4EHSD17B10ALOX15
SCHEMBL25404852 0.92 SMN1; SMN2 (0.51) SMN1; SMN2USP2KDM4EHSD17B10ALOX15
SCHEMBL15068058 0.92 SMN1; SMN2 (0.56) SMN1; SMN2USP2KDM4EHSD17B10ALOX15
SCHEMBL26270891 0.86 HSD17B10 (0.61) SMN1; SMN2USP2KDM4EHSD17B10ALOX15
SCHEMBL25148143 0.84 SMN1; SMN2 (0.45) SMN1; SMN2USP2KDM4EHSD17B10ALOX15
SCHEMBL4026767 0.84 ALDH1A1 (0.43) SMN1; SMN2HTR4MEN1KMT2AHTT
SCHEMBL4180063 0.84 CTSK (0.43) SMN1; SMN2USP2HTR4MEN1KMT2A
SCHEMBL28351674 0.83 ALDH1A1 (0.46) SMN1; SMN2MEN1KMT2AHTTALDH1A1
SCHEMBL303434 0.83 ALDH1A1 (0.46) SMN1; SMN2MEN1KMT2AHTTALDH1A1
SCHEMBL26270895 0.81 SMN1; SMN2 (0.42) SMN1; SMN2USP2KDM4EHSD17B10ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240317752-A1 6-SUBSTITUTED-9H-PURINE DERIVATIVES AND RELATED USES BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-09-26 US disclosed
CN-115244047-A Indazole derivative and application thereof in medicine 四川海思科制药有限公司 2022-10-25 CN disclosed
WO-2022178256-A1 6-SUBSTITUTED-9H-PURINE DERIVATIVES AND RELATED USES BLACK DIAMOND THERAPEUTICS, INC. (US) 2022-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240317752-A1 6-SUBSTITUTED-9H-PURINE DERIVATIVES AND RELATED USES TYMP, DPYD, PNP SMN1; SMN2 1068/4885USP2 4810/4885KDM4E 3183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.